Screener
Amrize AMRZ Impairment Charges
Impairment Charges at other companies
Other financials
Where this comes from
Reported directly by Amrize in its filing.
Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.
The source filing: Amrize’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 4:05 PM EST
- Fiscal year
- FY2025
- Accession
- 0002035989-26-000017
| Line item | For the years ended December 31, 2025 | For the years ended December 31, 2024 | For the years ended December 31, 2023 |
|---|---|---|---|
| Gross profit | 3,034 | 3,070 | 2,769 |
| Selling, general and administrative expenses | (1,128) | (944) | (898) |
| Gain on disposal of long-lived assets | 15 | 71 | 32 |
| Loss on impairments | (15) | (2) | (15) |
| Operating income | 1,906 | 2,195 | 1,888 |
| Interest expense, net | (413) | (512) | (549) |
| Other non-operating income (expense), net | 4 | (55) | (36) |
| Income before income tax expense and income from equity method investments | 1,497 | 1,628 | 1,303 |
Item 8. Financial Statements & Supplementary Data
FAQ
- What is Amrize's impairment charges?
- Amrize (AMRZ) reported impairment charges of $3.75M in Q4 2025.
- How has Amrize's impairment charges changed year-over-year?
- Amrize's impairment charges increased by 650.0% year-over-year, from $500K to $3.75M.
- What is the long-term trend for Amrize's impairment charges?
- Over 2 years (2023 to 2025), Amrize's impairment charges has grown at a 0.0% compound annual growth rate (CAGR), from $15M to $15M.
- What does impairment charges mean?
- Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.
Ask your AI about Amrize's impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude